About Us: Where Operating Experience Meets Market Reality
The discipline:
NeArco Capital is a commercial intelligence firm. Fundamental analysis weighs the numbers a company reports. Technical analysis reads its price. Commercial intelligence reads what both leave out: who pays, on what terms, and whether they come back; how a first customer becomes a second and a tenth; what a contract actually obligates once the announcement is read against the filing; where the company stands with its customers and against its competition; whether its product is part of a bigger thematic narrative; how it prices, how it sells, and how long the sale takes; and whether the company's account of itself matches what its contracts, its receivables, and its renewals show. It is gathered the way an operator gathers it, through discovery: probing questions that surface the second-order facts a first answer leaves out. Set beside its better-known relatives, it fills the gap between them, and every reading is graded on two things kept apart: how strongly the evidence points, and how far it can be trusted.
The conviction:
The firm is founded on a conviction formed over three decades on the commercial side: beyond fundamentals and technicals, a company's value lives in how well it builds long-lasting customer engagements.
The evidence:
Durable engagements leave evidence, in who pays first, what they sign, how contracts convert, and whether customers return. NeArco reads that evidence the way an experienced operator reads a pipeline, separating commitment from conversation.
Where the firm works, and why:
The firm applies this lens to the physical economy behind the digital one, covering the buildouts: industries where the future is financed years before it is delivered, and where outcomes diverge further than anywhere else in public markets. A power grid, a copper mine, or an industrial supply chain cannot be downloaded from the cloud, and the constraints that decide these industries clear on physical and regulatory timelines that demand cannot compress. In these arenas capital arrives ahead of evidence, companies are priced on what they intend to build, and the winners compound for a decade while the rest never convert. That is exactly where the two conventional lenses work worst: before a business stabilizes, the numbers fundamental analysis is handed are the company's own projections, and the tape technical analysis reads reflects narrative and positioning rather than anything underneath. The commercial read is the one both are missing.
The universe:
The coverage universe is public scale-ups, in or approaching commercialization: companies already trading, with established products, expanding end-markets, and large addressable markets, whose forward run-rate is still a forecast. A public scale-up carries venture-stage questions alongside public-market evidence, filings, prints, and contracts the examination can grade.
How the examination runs:
The firm reads a company the way three decades of consultative business development learned to read a customer, through the SPIN discipline of Neil Rackham's research, Situation, Problem, Implication, Need-payoff: understand their world from evidence before advancing anything, find the real problem beneath the stated one, follow its cost until the full weight is visible, and only then let an answer earn its hearing. The problems that matter most are the ones no one has named yet, and by the time they surface on their own the cost has compounded; the examination exists to name them first. Every claim answers the three questions of feature, function, and benefit: what it is, what it does, and what it is worth to the customer who pays for it. A potential is worth zero until it is proven. What the firm expects is written down before the evidence arrives, and when the evidence arrives, it is graded, whatever it says.
One examination, three uses:
The commercial read comes first, and where it holds the firm translates it into market terms: capital structure, valuation, and the moments where price and the underlying business diverge. The firm researches a business, understands it, invests its own capital where the evidence warrants, and applies what it learned to the companies it advises. The published record, the firm's own book, and the market development practice all run on the same examination, and each of the three grades the other two.
Why this size and stage:
The firm's expertise fits public scale-ups because of what decides their outcome. At small and mid capitalizations a company's fate turns on a handful of contracts and delivery dates, and reading those is exactly what three decades of building enterprise pipelines trained. Coverage is thin at this size, so a correct reading is rarely already in the price. Above the index line the picture reverses: market positions are settled, dozens of analysts price every filing, and passive flows move the tape regardless of what any one contract says, which leaves an operator's read little to add.
The constant:
The lens that reads a power-interconnection queue reads a regulatory approval pathway or a clinical-development timeline the same way. The industries will change as the decade does. The examination stays the same.